Orbotech Ltd. (NASDAQ:ORBK) currently has an Average Broker Rating of 1. This number is based on the 5 sell-side firms polled by Zacks. The ABR rank within the industry stands at 15.
Analysts on a consensus basis are expecting that the stock will reach $41.33 within the year. The ABR is provided by Zacks which simplfies analyst ratings into an integer based number. They use a one to five scale where they translate brokerage firm Buy/Sell/Hold recommendations into an average broker rating. A low number in the 1-2 range typically indicates a Buy, 3 represents a Hold and 4-5 represents a consensus Sell rating.
Research analysts study publicly traded companies and make recommendations on the securities of those companies. Most specialize in a particular industry or sector of the economy. They exert considerable influence in today’s marketplace. Analysts’ recommendations or reports can influence the price of a company’s stock—especially when the recommendations are widely disseminated through television appearances or through other electronic and print media. The mere mention of a company by a popular analyst can temporarily cause its stock to rise or fall—even when nothing about the company’s prospects or fundamentals has recently changed.
Analysts often use a variety of terms—buy, strong buy, near-term or long-term accumulate, near-term or long-term over-perform or under-perform, neutral, hold—to describe their recommendations. But the meanings of these terms can differ from firm to firm. Rather than make assumptions, investors should carefully read the definitions of all ratings used in each research report. They should also consider the firm’s disclosures regarding what percentage of all ratings fall into either “buy,” “hold/neutral,” and “sell” categories.
Stock analysis typically falls under the two main categories of fundamental and technical. Fundamental analysis involves diving into company financials. Fundamental analysts study how the company is performing in order to determine whether or not the stock is ready to run. With this type of analysis, investors will be looking at balance sheet strength and gauging how much money the company is giving back to shareholders. After crunching all the numbers, investors can use the information to calculate ratios to help determine if the company is properly valued and worth adding to the portfolio. Technical analysis relies on charting historical stock prices in order to define trends and patterns. The buying and selling of stocks using only technical analysis typically removes any concern for how the company is fairing or even what it actually does. Some indicators that technical analysts use can be super simple and others can be highly complex. Many investors will attempt to study both technicals and fundamentals with the goal of gaining greater knowledge of where the stock has been, and where it might be going.
Research analysts are predicting that Orbotech Ltd. (NASDAQ:ORBK) will report earnings of $0.81 per share when the firm issues their next quarterly report. This is the consensus earnings per share number according to data from Zack’s Research.
Most recently Orbotech Ltd. (NASDAQ:ORBK) posted quarterly earnings of $0.67 which compared to the sell-side estimates of 0.85. The stock’s 12-month trailing earnings per share stands at $2.51. Shares have moved $1.56 over the past month and more recently, $0.83 over the past week heading into the earnings announcement. There are 3 analyst projections that were taken into consideration from respected brokerage firms.
Orbotech Ltd. (NASDAQ:ORBK) closed the last session at $42.39 and sees an average of 294034.94 shares trade hands in each session. The 52-week low of the stock stands at $27.07 while the current level stands at 95.45% of the 52-week High-Low range. Looking further out we can see that the stock has moved 19.01% over the past 12 weeks and 26.88% year to date.
5 analysts rate Orbotech Ltd. a Buy or Strong Buy, which is 100% of all the analyst ratings.
This article is informational purposes only and should not be considered a recommendation to buy or sell the stock.